Skip to content
Penetrating, critical, and timely research and commentaries for stable and equitable growth
theAirnet.org
  • HOME
  • ABOUT
    • MISSION
    • THE NETWORK
  • RESEARCH
    • REPORTS
    • BOOKS
  • IEA
  • DEBATE
    • ANALYSIS
    • IMPACT
    • BLOG – COMING SOON
  • PARTNERS
    • * INET-AIR COVID VACCINE PROJECT (CVP)
    • * CIFAR-AIR Projects on Innovation, Equity & Prosperity
    • * BA-SOAS-AIR Conference on Global Vaccine Equity
  • CONTACT
  • SUPPORT AIR
AIR IMPACT

US biopharmaceutical finance and the sustainability of the biotech business model

November 29, 2011admin

theAIRnet researchers, William Lazonick and Öner Tulum, have published an article, “US biopharmaceutical finance and the sustainability of the biotech business model“, in the latest issue of Research Policy.

Post navigation

Previous Post Plan B: A Good Economy for a Good Society
Next Post Innovative Business Models and Varieties of Capitalism: The Financialization of the US Corporation
Facebook Twitter LinkedIn YouTube Rssfeed
© 2025 theAirnet.org
  • HOME
  • ABOUT
    • MISSION
    • THE NETWORK
  • RESEARCH
    • REPORTS
    • BOOKS
  • IEA
  • DEBATE
    • ANALYSIS
    • IMPACT
    • BLOG – COMING SOON
  • PARTNERS
    • * INET-AIR COVID VACCINE PROJECT (CVP)
    • * CIFAR-AIR Projects on Innovation, Equity & Prosperity
    • * BA-SOAS-AIR Conference on Global Vaccine Equity
  • CONTACT
  • SUPPORT AIR
theAirnet.orgLogo Header Menu
  • HOME
  • ABOUT
    • MISSION
    • THE NETWORK
  • RESEARCH
    • REPORTS
    • BOOKS
  • IEA
  • DEBATE
    • ANALYSIS
    • IMPACT
    • BLOG – COMING SOON
  • PARTNERS
    • * INET-AIR COVID VACCINE PROJECT (CVP)
    • * CIFAR-AIR Projects on Innovation, Equity & Prosperity
    • * BA-SOAS-AIR Conference on Global Vaccine Equity
  • CONTACT
  • SUPPORT AIR